cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study

NCT03243604 · clinicaltrials.gov ↗

COMPLETED

Status

1717

Enrollment

OTHER

Sponsor class

Conditions

Arrhythmias, Cardiac
Atrial Fibrillation and Flutter
Tachycardia, Supraventricular
Cardiac Failure

Interventions

DRUG: L02 (sex hormones used in treatment of neoplastic diseases) and G03 (sex hormones)

Sponsor

Groupe Hospitalier Pitie-Salpetriere